RESEARCH-USE BIOSIMILAR ANTIBODY
Pidilizumab
Monoclonal antibody · IgG1
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-267
CATALOG NUMBERSC-BS-267
MOLECULAR WEIGHTApprox. 144.626 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research.
Pidilizumab is a recombinant research-use antibody directed against PDCD1.